Microsoft CDR CAD Hedged (MSFT) Börsenkurse

Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference

WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Form 8-K - Current report

Microsoft launches $5 million AI for Good Open Call grant program to drive positive change in Washington state

Microsoft launches $5 million AI for Good Open Call grant program to drive positive change in Washington state PR Newswire REDMOND, Wash., Jan. 22, 2025 New program celebrates 50 years of...

Pearson and Microsoft Announce Multi-Year Partnership to Transform the Future of Learning and Work with AI

Pearson and Microsoft Announce Multi-Year Partnership to Transform the Future of Learning and Work with AI PR Newswire LONDON and REDMOND, Wash., Jan. 14, 2025 Both companies are committing to...

Microsoft announces quarterly earnings release date

Microsoft announces quarterly earnings release date PR Newswire REDMOND, Wash., Jan. 9, 2025 REDMOND, Wash., Jan. 9, 2025 /PRNewswire/ -- Microsoft Corp. will publish fiscal year 2025...

U.S. Stocks May See Further Downside After Friday’s Sell-Off

The major U.S. index futures are currently pointing to a lower open on Monday, with stocks likely to see further downside following the sharp pullback seen last Friday. Concerns about a recent...

Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...